Peel Hunt assumed coverage on shares of Luceco (LON:LUCE) in a research note released on Wednesday, ThisIsMoney.Co.Uk reports. The brokerage issued an add rating and a GBX 120 ($1.57) target price on the stock.

Separately, Numis Securities reiterated a buy rating and set a GBX 115 ($1.50) target price on shares of Alliance Pharma in a research report on Friday, May 24th.

LUCE opened at GBX 103.20 ($1.35) on Wednesday. The firm’s fifty day simple moving average is GBX 117.57. The stock has a market cap of $165.95 million and a PE ratio of 114.67. The company has a current ratio of 1.29, a quick ratio of 0.72 and a debt-to-equity ratio of 88.35. Luceco has a 52-week low of GBX 32.10 ($0.42) and a 52-week high of GBX 133 ($1.74).

About Luceco

Luceco plc manufactures and distributes various light emitting diode (LED) lighting products and wiring accessories in the United Kingdom, Europe, the Middle East, the Americas, the Asia Pacific, and Africa. It operates through four segments: Wiring Accessories, Portable Power, LED Lighting, and Ross and Other.

Recommended Story: Holder of Record

Receive News & Ratings for Luceco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luceco and related companies with MarketBeat.com's FREE daily email newsletter.